Vaccine Therapies for Prostate Cancer: Current Status and Future Outlook

被引：1

作者：

Zhou, Wenhao ^{[1
]}

Lu, Xiaojun ^{[1
]}

Tian, Feng ^{[2
]}

Luo, Qianming ^{[3
]}

Zhou, Weihang ^{[3
]}

Yang, Siyuan ^{[3
]}

Li, Wenxuan ^{[4
]}

Yang, Yongjun ^{[4
]}

Shi, Minfeng ^{[5
]}

Zhou, Tie ^{[1
]}

机构：

[1] Tongji Univ, Shanghai Peoples Hosp 4, Sch Med, Dept Urol, Shanghai 200434, Peoples R China

[2] Shanghai Eighth Peoples Hosp, Dept Urol, Shanghai 200235, Peoples R China

[3] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China

[4] Naval Med Univ, Coll Clin Med, Shanghai 200433, Peoples R China

[5] Naval Med Univ, Changhai Hosp, Reprod Ctr, Shanghai 200433, Peoples R China

来源：

VACCINES | 2024年 / 12卷 / 12期

关键词：

prostate cancer; cancer vaccines; immunotherapy; combination therapies; PERSONALIZED PEPTIDE VACCINATION; ANDROGEN DEPRIVATION THERAPY; PHASE I/II TRIAL; SIPULEUCEL-T; CELLULAR IMMUNOTHERAPY; IMMUNOLOGICAL EFFICACY; CLINICAL-TRIAL; DNA VACCINES; II TRIAL; ANTIGEN;

D O I：

10.3390/vaccines12121384

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Prostate cancer is a prevalent cancer in elderly men, and immunotherapy has emerged as a promising treatment approach in recent years. The aim of immunotherapy is to stimulate the body's immune system to target and destroy cancer cells. Cancer vaccines that are highly specific, safe, and capable of creating long-lasting immune responses are a key focus in cancer immunotherapy research. Despite progress in clinical trials showing positive results, the practical use of cancer vaccines still encounters various obstacles. The complexity of the immune microenvironment and variations in the immune systems of individual patients have hindered the progress of research on prostate cancer vaccines. This review examines the history and mechanisms of cancer vaccines, summarizes recent clinical research findings, and explores future directions in the development of prostate cancer vaccines.

引用

页数：15

共 50 条

[31] Focal therapy for prostate cancer: current status and future perspectives
Miano, R.
Asimakopoulos, A. D.
Da Silva, R. D.
Bove, P.
Jones, S. J.
De La Rosette, J. J.
Kim, F. J.
MINERVA UROLOGICA E NEFROLOGICA, 2015, 67 (03) : 263 - 280
[32] Fatty acids and prostate cancer: current status and future challenges
Pandian, SS
Eremin, OE
McClinton, S
Wahle, KWJ
Heys, SD
JOURNAL OF THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH, 1999, 44 (06): : 352 - 361
[33] PSA Screenings for Prostate Cancer: Current Status, Future Directions
Godley, Paul A.
ONCOLOGIST, 2012, 17 : 8 - 8
[34] The treatment of neuroendocrine prostate cancer; current status and future directions
Rescigno, Pasquale
INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2019, 6 (03)
[35] Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
Li, Huanye
Lee, Chau Hung
Chia, David
Lin, Zhiping
Huang, Weimin
Tan, Cher Heng
DIAGNOSTICS, 2022, 12 (02)
[36] Current status of local salvage therapies following radiation failure for prostate cancer
Touma, NJ
Izawa, JI
Chin, JL
JOURNAL OF UROLOGY, 2005, 173 (02): : 373 - 379
[37] Onconephrology Fellowship Training: Current Status and Future Outlook
Bonilla, Macro
Geara, Abdallah S.
KIDNEY360, 2024, 5 (09): : 1380 - 1385
[38] Diffuse correlation spectroscopy: current status and future outlook
Carp, Stefan A.
Robinson, Mitchell B.
Franceschini, Maria A.
NEUROPHOTONICS, 2023, 10 (01)
[39] Sunscreens in the United States: Current Status and Future Outlook
Glaser, Katherine S.
Tomecki, Kenneth J.
SUNLIGHT, VITAMIN D AND SKIN CANCER, 3RD EDITION, 2020, 1268 : 355 - 379
[40] Current status of FCV development and future outlook for FCVs
Tange, Shoji
Review of Automotive Engineering, 2008, 29 (04) : 455 - 461

← 1 2 3 4 5 →